Genoray Co., Ltd. (KOSDAQ:122310)
3,325.00
+5.00 (0.15%)
At close: Jul 10, 2026
Genoray Market Cap
Genoray has a market cap or net worth of 42.33 billion as of July 10, 2026. Its market cap has decreased by -41.13% in one year.
Market Cap
42.33B
Enterprise Value
56.83B
Revenue
108.27B
Ranking
n/a
PE Ratio
185.56
Stock Price
3,325.00
Market Cap Chart
Since May 28, 2018, Genoray's market cap has decreased from 150.47B to 42.33B, a decrease of -71.87%. That is a compound annual growth rate of -14.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 42.33B | -16.23% |
| Dec 30, 2025 | 50.53B | -27.84% |
| Dec 30, 2024 | 70.03B | -26.75% |
| Dec 28, 2023 | 95.60B | -11.63% |
| Dec 29, 2022 | 108.18B | -23.55% |
| Dec 30, 2021 | 141.51B | 1.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| May 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SELVAS Healthcare | 66.61B |
| Hironic | 58.03B |
| Dynamic solution | 55.06B |
| DRGEM | 54.48B |
| QuantaMatrix | 45.91B |
| JPI Healthcare | 37.47B |
| Noul Co.,Ltd. | 34.01B |
| UXN Co., Ltd. | 29.39B |